EARNEST Partners’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | -$5 | – | 342 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1163 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1170 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1166 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1171 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1124 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1146 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1152 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1163 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1166 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1171 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1175 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1077 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1163 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1149 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1112 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1166 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1157 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1169 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1174 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1180 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1093 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1100 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1075 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1070 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 285 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1145 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 380 |
|
Other funds holding APVO
SM
SSA
AC
CF
